| Population density and basic reproductive number of COVID-19 across United States counties KTL Sy, LF White, BE Nichols PloS one 16 (4), e0249271, 2021 | 256 | 2021 |
| Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical … JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ... The Lancet Global Health 2 (1), e23-e34, 2014 | 248 | 2014 |
| Sustainable HIV treatment in Africa through viral-load-informed differentiated care A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ... Nature 528 (7580), S68-S76, 2015 | 175 | 2015 |
| Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study BE Nichols, CAB Boucher, M van der Valk, BJA Rijnders, ... The Lancet Infectious Diseases 16 (12), 1423-1429, 2016 | 136 | 2016 |
| Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron K van der Straten, D Guerra, MJ van Gils, I Bontjer, TG Caniels, ... Immunity 55 (9), 1725-1731. e4, 2022 | 133* | 2022 |
| Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub‐Saharan Africa: a rapid systematic review L Long, S Kuchukhidze, S Pascoe, BE Nichols, MP Fox, R Cele, ... Journal of the International AIDS Society 23 (11), e25640, 2020 | 132 | 2020 |
| Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models DAMC Van De Vijver, BE Nichols, UL Abbas, CAB Boucher, V Cambiano, ... Aids 27 (18), 2943-2951, 2013 | 104 | 2013 |
| HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making HIV Modelling Consortium Treatment as Prevention Editorial Writing Group PLoS Medicine 9 (7), e1001259, 2012 | 101 | 2012 |
| Effect of facility-based HIV self-testing on uptake of testing among outpatients in Malawi: a cluster-randomised trial K Dovel, F Shaba, OA Offorjebe, K Balakasi, M Nyirenda, K Phiri, ... The Lancet Global Health 8 (2), e276-e287, 2020 | 96* | 2020 |
| Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study AN Phillips, V Cambiano, F Nakagawa, P Revill, MR Jordan, TB Hallett, ... The lancet HIV 5 (3), e146-e154, 2018 | 84 | 2018 |
| Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa Y Jo, L Jamieson, I Edoka, L Long, S Silal, JRC Pulliam, H Moultrie, ... Open Forum Infectious Diseases 8 (3), ofab040, 2021 | 57 | 2021 |
| Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study BE Nichols, CAB Boucher, JH van Dijk, PE Thuma, JL Nouwen, ... PLoS One 8 (3), e59549, 2013 | 55 | 2013 |
| Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men S Popping, SJ Hullegie, A Boerekamps, BJA Rijnders, RJ de Knegt, ... PLoS One 14 (1), e0210179, 2019 | 48* | 2019 |
| Differentiated service delivery models for HIV treatment in Malawi, South Africa, and Zambia: a landscape analysis A Huber, S Pascoe, B Nichols, L Long, S Kuchukhidze, B Phiri, T Tchereni, ... Global Health: Science and Practice 9 (2), 296-307, 2021 | 46 | 2021 |
| Community-based delivery of HIV treatment in Zambia: costs and outcomes BE Nichols, R Cele, L Jamieson, LC Long, Z Siwale, P Banda, C Moyo, ... Aids 35 (2), 299-306, 2021 | 46 | 2021 |
| Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058 DAMC van de Vijver, AK Richter, CAB Boucher, ... Eurosurveillance 24 (7), 1800398, 2019 | 45 | 2019 |
| Quality of life among people living with HIV in England and the Netherlands: a population-based study S Popping, M Kall, BE Nichols, E Stempher, L Versteegh, ... The Lancet Regional Health–Europe 8, 2021 | 42 | 2021 |
| Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled … L Jamieson, LF Johnson, BE Nichols, S Delany-Moretlwe, ... The Lancet HIV 9 (12), e857-e867, 2022 | 39* | 2022 |
| SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs AX Han, A Toporowski, JA Sacks, MD Perkins, S Briand, M Van Kerkhove, ... Nature Genetics 55 (1), 26-33, 2023 | 38* | 2023 |
| Monitoring viral load for the last mile: what will it cost? BE Nichols, SJ Girdwood, T Crompton, L Stewart‐Isherwood, L Berrie, ... Journal of the International AIDS Society 22 (9), e25337, 2019 | 38 | 2019 |
Sydney RosenProfessor of Global Health, Boston University在 bu.edu 的电子邮件经过验证
